药学与临床研究2024,Vol.32Issue(3) :204-208.

云芝胞内糖肽口服制剂质量评价

Quality Evaluation of Coriolus Versicolor Intracellular Glycopeptides Oral Preparations

张圆 尹菁 周小华 石蓓佳 陆益红
药学与临床研究2024,Vol.32Issue(3) :204-208.

云芝胞内糖肽口服制剂质量评价

Quality Evaluation of Coriolus Versicolor Intracellular Glycopeptides Oral Preparations

张圆 1尹菁 1周小华 1石蓓佳 1陆益红1
扫码查看

作者信息

  • 1. 江苏省食品药品监督检验研究院,南京 210019
  • 折叠

摘要

目的:了解云芝胞内糖肽口服制剂的质量现状并发现存在的质量问题,完善质量标准,为药品监管提供技术支持.方法:从全国范围内抽取54批次云芝胞内糖肽口服制剂样品,依据现行质量标准检验,从药品安全性、有效性等方面进行探索性研究,建立多项检测方法全面分析其质量情况.结果及结论:云芝胞内糖肽口服制剂在原料工艺和制剂工艺中均发现与批准工艺不符的问题,其质量标准有待完善和提高.

Abstract

Objective:To analyze the overall quality status and related quality problems of Coriolus ver-sicolor intracellular glycopeptides oral preparations in order to improve the quality standard and provide technical support for drug supervision.Methods:According to the current quality standard,54 batches of Coriolus versicolor intracellular glycopeptides oral preparations from the whole country were tested.Moreover,based on the problems found in the tests,exploratory research was carried out in aspects of authenticity,safety and effectiveness of these drugs,and a number of detection methods were established to fully analyze their quality.Results & Conclusion:It is found that the raw material process and preparation process are inconsistent with the approved processes,and the quality standards need to be improved.

关键词

云芝胞内糖肽/口服制剂/质量评价

Key words

Coriolus versicolor intracellular glycopeptides/Oral preparations/Quality evaluation

引用本文复制引用

基金项目

国家科技重大专项(2015ZX09303001)

出版年

2024
药学与临床研究
江苏省药学会

药学与临床研究

CSTPCD
影响因子:0.95
ISSN:1673-7806
参考文献量9
段落导航相关论文